Join the Sacred Journey

Yes. Numerous studies support psilocybin as a ‘breakthrough therapy,’ a designation granted by the FDA. This recognition continues to drive groundbreaking research into psilocybin and other serotonergic psychedelics.

Dr. Robin Carhart-Harris is a leading figure in psychedelic research, particularly known for his studies on psilocybin’s potential in treating mental health conditions. His work has significantly contributed to the resurgence of interest in psychedelic-assisted therapy.

A landmark 2016 study published in The Lancet Psychiatry by Dr. Robin Carhart-Harris and colleagues explored the use of psilocybin with psychological support for people with treatment-resistant depression. Just two guided sessions led to rapid and significant reductions in depressive symptoms, with some participants experiencing lasting improvement for up to three months.
 Read the full study here: https://doi.org/10.1016/S2215-0366(16)30065-7

Six-Month Follow-Up Study
 A follow-up study extended the findings, demonstrating that the antidepressant effects of psilocybin could persist for at least six months post-treatment. This study provided preliminary support for the safety and efficacy of psilocybin in treatment-resistant depression.

Brain Imaging Studies

Functional MRI studies conducted by Carhart-Harris revealed that psilocybin therapy leads to increased global brain network integration. This neural reorganization is associated with rapid and sustained antidepressant effects, indicating a potential mechanism by which psilocybin alleviates depression.

Both approaches offer unique and valuable benefits—it really comes down to your personal intentions. If you’re new to this work and feel called to begin gently, microdosing can provide a gradual, sustained path of attunement. On the other hand, a therapeutic dose may catalyze more immediate and profound shifts.

Microdosing within a structured protocol with a therapeutic dose(s) will exponentially increase neuroplasticity, and maximize the “critical learning period” , a window of opportunity where the brain is more susceptible to learning, novel perceptions and self-discovery.

Read more about the “Critial learning period” with psychedelics at John’s Hopkins: https://www.hopkinsmedicine.org/news/newsroom/news-releases/2023/06/study-shows-psychedelic-drugs-reopen-critical-periods-for-social-learning

 I work with people who are ready to engage deeply with their own healing and growth—those who feel called to partner with the unfolding process rather than seeking a quick fix. Psychedelics can open powerful doors, but the real transformation begins when limiting patterns are identified and new strategies are employed that foster resilience and empowerment.

Many of my clients come seeking support with depression, grief, trauma resolution, or simply curious about experiencing new states of consciousness.  Others are drawn to this work to deepen spiritual inquiry, expand creativity, or move into the next level of performance, vitality, and well-being.

I also support those focused on health optimization and conscious life design.

Many clients notice positive shifts after just one session (psilocybin or cannabis), though lasting change is probable with multiple sessions. There’s no fixed formula—each person’s neurobiology and unique history guide the process. Lasting transformation tends to unfold when clients are committed to their growth process, stay engaged, curious, and open.

No matter your path, my role is to support you in reconnecting with your inner strength, clarity, and purpose—so you can live from that place with trust and intention.

Yes. Colorado’s path to legalizing natural psychedelics began with Proposition 122 (Natural Medicine Health Act) in November 2022, decriminalizing the personal use, possession, cultivation, and sharing of certain natural psychedelics for adults 21+.

Sacred Peaks Retreat is a state-licensed healing center operating under Colorado’s Natural Medicine Program and regulated by the Natural Medicine Division of the Colorado Department of Revenue.

I am a Licensed Psilocybin Facilitator in Training through the Department of Regulatory Agencies (DORA).

Psilocybin administration sessions are provided by state-licensed facilitators and are intended for personal growth, reflection, and wellness support

Psilocybin journeys can occasionally include periods of emotional intensity or difficulty. These experiences are usually transitory and often meaningful parts of the healing process.

Careful attention to set and setting—the mindset participants bring into the experience and the safe, supportive environment in which it unfolds—plays a vital role in helping individuals navigate these moments with greater ease and trust.

Expanded states of awareness may allow previously stored memories, emotions, or unconscious patterns to surface. When held within a prepared mindset and a thoughtfully guided setting, these experiences can be revisited and processed with new perspective and compassion.

Many participants find that moving through these moments leads to emotional release, insight, and a deeper sense of wholeness and personal empowerment.